Source: Clinical nuclear medicine. Unidade: FM
Subjects: DOSIMETRIA, RADIAÇÃO (ENERGIA RADIANTE), CRIANÇAS, NEUROBLASTOMA, FAMÍLIA (PSICOLOGIA)
ABNT
WILLEGAIGNON, Jose et al. Pediatric 131I-MIBG therapy for neuroblastoma: whole-Body 131I-MIBG clearance, radiation doses to patients, family caregivers, medical staff, and radiation safety measures. Clinical nuclear medicine, v. 43, n. 8, p. 572-578, 2018Tradução . . Disponível em: https://doi.org/10.1097/RLU.0000000000002158. Acesso em: 16 out. 2024.APA
Willegaignon, J., Crema, K. P., Oliveira, N. C., Pelissoni, R. A., Coura-Filho, G. B., Sapienza, M. T., & Buchpiguel, C. A. (2018). Pediatric 131I-MIBG therapy for neuroblastoma: whole-Body 131I-MIBG clearance, radiation doses to patients, family caregivers, medical staff, and radiation safety measures. Clinical nuclear medicine, 43( 8), 572-578. doi:10.1097/RLU.0000000000002158NLM
Willegaignon J, Crema KP, Oliveira NC, Pelissoni RA, Coura-Filho GB, Sapienza MT, Buchpiguel CA. Pediatric 131I-MIBG therapy for neuroblastoma: whole-Body 131I-MIBG clearance, radiation doses to patients, family caregivers, medical staff, and radiation safety measures [Internet]. Clinical nuclear medicine. 2018 ; 43( 8): 572-578.[citado 2024 out. 16 ] Available from: https://doi.org/10.1097/RLU.0000000000002158Vancouver
Willegaignon J, Crema KP, Oliveira NC, Pelissoni RA, Coura-Filho GB, Sapienza MT, Buchpiguel CA. Pediatric 131I-MIBG therapy for neuroblastoma: whole-Body 131I-MIBG clearance, radiation doses to patients, family caregivers, medical staff, and radiation safety measures [Internet]. Clinical nuclear medicine. 2018 ; 43( 8): 572-578.[citado 2024 out. 16 ] Available from: https://doi.org/10.1097/RLU.0000000000002158